Skip to main content

New poliovirus therapy offers improved survival for recurrent glioblastoma

Tuesday, June 26, 2018

A therapy developed by a team of researchers including Annick Desjardins, MD, and colleagues at the Duke Department of Neurosurgery offers improved long-term survival for patients with recurrent glioblastoma. The poliovirus therapy increased the percentage of patients surviving for three years to 21 percent, compared to just 4 percent of patients who received standard treatments. Read this full story on the Department of Neurosurgery's website.